X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33912) 33912
Newsletter (963) 963
Book Chapter (130) 130
Dissertation (57) 57
Magazine Article (41) 41
Newspaper Article (26) 26
Conference Proceeding (22) 22
Book / eBook (18) 18
Publication (14) 14
Web Resource (7) 7
Journal / eJournal (3) 3
Reference (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (23162) 23162
life sciences & biomedicine (20882) 20882
humans (17165) 17165
pseudomonas aeruginosa (13829) 13829
microbiology (10294) 10294
pseudomonas aeruginosa - drug effects (7088) 7088
male (6832) 6832
female (6734) 6734
animals (6521) 6521
pseudomonas infections - microbiology (6376) 6376
bacteria (6006) 6006
pseudomonas aeruginosa - isolation & purification (5500) 5500
infectious diseases (4842) 4842
anti-bacterial agents - pharmacology (4597) 4597
microbial sensitivity tests (4248) 4248
adult (4002) 4002
pseudomonas aeruginosa - genetics (3920) 3920
pseudomonas infections - drug therapy (3872) 3872
research (3751) 3751
research article (3572) 3572
middle aged (3467) 3467
antibiotics (3393) 3393
pathogens (3159) 3159
infections (3091) 3091
immunology (3039) 3039
cystic fibrosis (3023) 3023
mice (2936) 2936
pseudomonas (2856) 2856
analysis (2855) 2855
health aspects (2790) 2790
anti-bacterial agents - therapeutic use (2775) 2775
pharmacology & pharmacy (2770) 2770
aged (2626) 2626
pseudomonas aeruginosa - pathogenicity (2513) 2513
virulence (2509) 2509
pseudomonas aeruginosa - physiology (2385) 2385
biofilms (2346) 2346
biochemistry & molecular biology (2343) 2343
pseudomonas aeruginosa - metabolism (2323) 2323
adolescent (2203) 2203
abridged index medicus (2079) 2079
cystic fibrosis - microbiology (2041) 2041
child (2034) 2034
bacterial proteins - genetics (2024) 2024
biotechnology & applied microbiology (1998) 1998
science & technology - other topics (1966) 1966
bacterial proteins - metabolism (1872) 1872
life sciences (1847) 1847
proteins (1829) 1829
mutation (1796) 1796
multidisciplinary sciences (1785) 1785
medicine (1754) 1754
pseudomonas aeruginosa - growth & development (1748) 1748
physiological aspects (1708) 1708
drug resistance (1691) 1691
gene expression (1685) 1685
pseudomonas infections - epidemiology (1599) 1599
cross infection - microbiology (1585) 1585
pseudomonas aeruginosa - immunology (1571) 1571
plant sciences (1564) 1564
genetic aspects (1561) 1561
molecular sequence data (1544) 1544
drug resistance in microorganisms (1505) 1505
pseudomonas infections - complications (1502) 1502
risk factors (1475) 1475
pseudomonas aeruginosa - enzymology (1467) 1467
infection (1460) 1460
respiratory system (1440) 1440
genes (1425) 1425
bacterial infections (1409) 1409
pseudomonas infections (1397) 1397
pseudomonas infections - immunology (1354) 1354
e coli (1349) 1349
cystic fibrosis - complications (1340) 1340
antimicrobial agents (1327) 1327
biochemical phenomena, metabolism, and nutrition (1321) 1321
child, preschool (1318) 1318
science (1268) 1268
staphylococcus aureus - drug effects (1260) 1260
drug resistance, bacterial (1245) 1245
bacteriology (1235) 1235
plant diseases - microbiology (1203) 1203
microorganisms (1192) 1192
biofilms - growth & development (1190) 1190
pseudomonas infections - etiology (1188) 1188
pseudomonas infections - diagnosis (1182) 1182
retrospective studies (1172) 1172
disease models, animal (1171) 1171
time factors (1154) 1154
biofilm (1149) 1149
biofilms - drug effects (1149) 1149
drug resistance, microbial (1141) 1141
escherichia coli - drug effects (1131) 1131
infant (1105) 1105
cell biology (1093) 1093
general & internal medicine (1086) 1086
biology (1084) 1084
pseudomonas - isolation & purification (1083) 1083
staphylococcus aureus (1063) 1063
anti-bacterial agents - administration & dosage (1043) 1043
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (33580) 33580
Japanese (525) 525
Russian (348) 348
French (344) 344
German (302) 302
Spanish (274) 274
Chinese (188) 188
Portuguese (126) 126
Polish (103) 103
Italian (99) 99
Turkish (51) 51
Romanian (27) 27
Danish (23) 23
Dutch (23) 23
Czech (19) 19
Hungarian (16) 16
Persian (16) 16
Swedish (11) 11
Korean (9) 9
Ukrainian (9) 9
Croatian (8) 8
Hebrew (7) 7
Serbian (7) 7
Bulgarian (6) 6
Slovak (6) 6
Norwegian (5) 5
Lithuanian (4) 4
Arabic (3) 3
Finnish (1) 1
Icelandic (1) 1
Indonesian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 1537-6613, 01/2015, Volume 211, Issue 1, pp. 156 - 165
Background. A predominantly T-helper type 2 (Th2) immune response is critical in the prognosis of pulmonary Pseudomonas aeruginosa infection... 
human-milk | cytokine production | butyrate | in-vitro | chain fatty-acids | galacto-oligosaccharides | t-cells | lactobacillus | virus-infection | cystic-fibrosis patients | intestinal microbiota | prebiotics | Th1 and M1 polarization | P. aeruginosa lung infection | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Intestines - drug effects | Lung Diseases - microbiology | GATA3 Transcription Factor - immunology | Pseudomonas aeruginosa - growth & development | Microbiota - drug effects | Male | T-Box Domain Proteins - immunology | Lung Diseases - drug therapy | Th1 Cells - immunology | Intestines - immunology | Leukocytes - immunology | Oligosaccharides - pharmacology | Leukocytes - microbiology | Tumor Necrosis Factor-alpha - immunology | Keratinocytes - microbiology | Macrophages - immunology | Macrophages - microbiology | Chemotactic Factors - immunology | Microbiota - immunology | Pseudomonas Infections - drug therapy | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Keratinocytes - immunology | Pectins - chemistry | Pseudomonas Infections - immunology | Lung Diseases - immunology | Interleukin-4 - immunology | Th1 Cells - microbiology | Animals | Intestines - microbiology | Interferon-gamma - immunology | Mice | Mice, Inbred BALB C | Interleukin-10 - immunology | Index Medicus | Abridged Index Medicus | Pseudomonas Infections/microbiology | Macrophages/microbiology | Oligosaccharides/pharmacology | Macrophages/immunology | Lung Diseases/immunology | Lung Diseases/microbiology | Interferon-gamma/immunology | Keratinocytes/microbiology | Microbiota/drug effects | Life Sciences | Leukocytes/microbiology | Pseudomonas Infections/immunology | Interleukin-10/immunology | Lung Diseases/drug therapy | T-Box Domain Proteins/immunology | Leukocytes/immunology | Pseudomonas aeruginosa/drug effects | Th1 Cells/microbiology | GATA3 Transcription Factor/immunology | Interleukin-4/immunology | Intestines/drug effects | Intestines/microbiology | Keratinocytes/immunology | Chemotactic Factors/immunology | Tumor Necrosis Factor-alpha/immunology | Microbiota/immunology | Pseudomonas aeruginosa/growth & development | Pectins/chemistry | Pseudomonas Infections/drug therapy | Th1 Cells/immunology | Intestines/immunology
Journal Article
Burns, ISSN 0305-4179, 05/2017, Volume 43, Issue 3, pp. 642 - 653
Highlights • Burn depth/agent increases risk of developing an infection. • Infections found folliculitis, burn wound, urinary tract, pneumonia, CVC and bloodstream... 
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Dermatology | Surgery | Science & Technology | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents | Index Medicus
Journal Article
The Journal of infection, ISSN 0163-4453, 09/2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial stewardship oversight significantly... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes | Index Medicus
Journal Article
Burns, ISSN 0305-4179, 02/2017, Volume 43, Issue 1, pp. 144 - 148
Highlights • Gram-positive organisms accounted for 66.4% of the causative pathogens for bloodstream infections (BSIs... 
Critical Care | Burn | Pediatric burn patients | Burn-associated bloodstream infections | Children | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Dermatology | Surgery | Science & Technology | Anti-Infective Agents - pharmacology | Humans | Candidiasis - epidemiology | Child, Preschool | Infant | Male | Candidiasis - microbiology | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | Time Factors | Gram-Positive Bacterial Infections - microbiology | Female | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Acinetobacter Infections - microbiology | Central Venous Catheters | Risk Factors | Burns - microbiology | Escherichia coli Infections - microbiology | Catheterization, Central Venous | Klebsiella Infections - microbiology | Fungemia - microbiology | Pseudomonas Infections - microbiology | Burns - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Turkey - epidemiology | Acinetobacter Infections - epidemiology | Catheter-Related Infections - microbiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Fungemia - epidemiology | Pediatrics | Burns and scalds | Health aspects | Diseases | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 06/2019, Volume 63, Issue 7
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 05/2017, Volume 64, Issue 10, pp. 1435 - 1444
Over the last 20 years there have been 32 reports of carbapenem-resistant organisms in the hospital water environment, with half of these occurring since 2010.... 
carbapenem-resistant | outbreak | carbapenemase | water | healthcare-associated infections | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - drug effects | Humans | Drug Resistance, Bacterial | beta-Lactamases - biosynthesis | Molecular Typing | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Carbapenem-Resistant Enterobacteriaceae - enzymology | Carbapenem-Resistant Enterobacteriaceae - genetics | Carbapenems - pharmacology | Disease Reservoirs - microbiology | Pseudomonas aeruginosa - enzymology | Klebsiella pneumoniae - genetics | Cross Infection - epidemiology | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Equipment and Supplies, Hospital - microbiology | Disinfection | Klebsiella Infections - microbiology | Pseudomonas aeruginosa - drug effects | Electrophoresis, Gel, Pulsed-Field | Pseudomonas Infections - microbiology | Hospitals | Pseudomonas Infections - epidemiology | Pseudomonas aeruginosa - genetics | Cross Infection - microbiology | Klebsiella pneumoniae - enzymology | Disease Outbreaks - prevention & control | Bacterial Proteins - biosynthesis | Water Supply | Carbapenem-Resistant Enterobacteriaceae - drug effects | Water Microbiology | Usage | Critically ill | Electrophoresis | Cross infection | Nosocomial infections | Health aspects | Risk factors | Index Medicus
Journal Article
British journal of nutrition, ISSN 0007-1145, 01/2015, Volume 113, Issue 2, pp. 191 - 199
.... Imbalanced fatty acid incorporation in membranes, including increased arachidonic acid and decreased DHA concentrations, is known to play a critical role in chronic inflammation associated with bacterial infection... 
Full Papers | Nutritional Immunology | Pseudomonas aeruginosa infection | Inflammation | n-3 Long-chain PUFA | Alkylglycerols | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Pseudomonas aeruginosa - immunology | Lung - microbiology | Pseudomonas aeruginosa - isolation & purification | Immunity, Mucosal | Male | Pneumonia, Bacterial - prevention & control | Pseudomonas Infections - prevention & control | Fish Oils - therapeutic use | Respiratory Mucosa - microbiology | Fishes | Respiratory Mucosa - immunology | Lung - metabolism | Respiratory Mucosa - secretion | Neutrophil Infiltration - immunology | Pneumonia, Bacterial - microbiology | Pseudomonas Infections - diet therapy | Cytokines - metabolism | Mice, Inbred C57BL | Cytokines - secretion | Bacterial Load | Permeability | Random Allocation | Immunity, Innate | Pneumonia, Bacterial - diet therapy | Pseudomonas Infections - microbiology | Liver - chemistry | Pseudomonas Infections - immunology | Animals | Survival Analysis | Fatty Acids, Omega-3 - therapeutic use | Pneumonia, Bacterial - immunology | Respiratory Mucosa - metabolism | Lung - secretion | Dietary Supplements | Lung - immunology | Immunologic Factors - therapeutic use | Bacterial infections | Immunology | Fish oils | Rodents | Lung diseases | Index Medicus | Pseudomonas Infections/microbiology | Pseudomonas aeruginosa/isolation & purification | Pneumonia, Bacterial/immunology | Neutrophil Infiltration/immunology | Respiratory Mucosa/microbiology | Pneumonia, Bacterial/prevention & control | Fatty Acids, Omega-3/therapeutic use | Life Sciences | Pseudomonas aeruginosa/immunology | Respiratory Mucosa/immunology | Liver/chemistry | Pseudomonas Infections/diet therapy | Pseudomonas Infections/immunology | Food and Nutrition | Cytokines/metabolism | Pulmonology and respiratory tract | Fish Oils/therapeutic use | Lung/metabolism | Lung/immunology | Pneumonia, Bacterial/diet therapy | Human health and pathology | Infectious diseases | Pseudomonas Infections/prevention & control | Lung/microbiology | Pneumonia, Bacterial/microbiology | Immunologic Factors/therapeutic use | Respiratory Mucosa/metabolism
Journal Article
PLoS pathogens, ISSN 1553-7374, 10/2008, Volume 4, Issue 10, pp. e1000184 - e1000184
Journal Article
PloS one, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, pp. e0176883 - e0176883
The quorum sensing (QS) circuit plays a role in the precise regulation of genes controlling virulence factors and biofilm formation in Pseudomonas aeruginosa.... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Virulence - drug effects | Prostheses and Implants - microbiology | Pseudomonas aeruginosa - physiology | Interferon-gamma - metabolism | Prosthesis-Related Infections - drug therapy | Dose-Response Relationship, Drug | Pseudomonas Infections - metabolism | Prosthesis-Related Infections - microbiology | Pseudomonas aeruginosa - pathogenicity | Female | Flavonoids - pharmacology | Drug Therapy, Combination | Disease Models, Animal | Biofilms - drug effects | Quorum Sensing - drug effects | Pseudomonas Infections - drug therapy | Interleukin-4 - metabolism | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Caenorhabditis elegans | Animals | Bacterial Proteins - metabolism | Prosthesis-Related Infections - metabolism | Virulence Factors - metabolism | Anti-Bacterial Agents - pharmacology | Mice, Inbred BALB C | Pseudomonas aeruginosa - ultrastructure | Peritoneum | Usage | Physiological aspects | Pseudomonas aeruginosa | Quorum sensing | Medicine, Chinese | Research | Virulence (Microbiology) | Surgical implants | Motility | Transplants & implants | Genes | Virulence | Inflammatory response | Infections | Drug resistance | Chinese medicine | Bacteria | Life sciences | Elastase | Nosocomial infections | Immune system | Pathogens | Immune response | Mortality | Staphylococcus infections | Cystic fibrosis | Gene expression | Mitigation | Biofilms | Hospitals | Antibiotics | Respiratory diseases | Nematodes | Mice | Infiltration | Interferon | In vitro methods and tests | Index Medicus
Journal Article